Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:50 am Unchanged |
2023-12-31 | 13G | Constellation Acquisition Corp I CSTAF |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:50 am Purchase |
2023-12-31 | 13G | Mammoth Energy Services, Inc. TUSK |
ADAGE CAPITAL PARTNERS GP L.L.C. | 4,275,000 8.920% |
1,147,732 (+36.70%) |
Filing History |
| 2024-02-07 07:46 am Sale |
2023-12-31 | 13G | ESGEN Acquisition Corporation ESAC |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-1,620,000 (Position Closed) |
Filing History |
| 2024-02-07 07:46 am Purchase |
2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 738,666 8.400% |
738,666 (New Position) |
Filing History |
| 2024-02-07 07:46 am Purchase |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
ADAGE CAPITAL PARTNERS GP L.L.C. | 5,537,500 8.970% |
2,437,362 (+78.62%) |
Filing History |
| 2024-02-07 07:45 am Sale |
2023-12-31 | 13G | TScan Therapeutics, Inc. TCRX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 3,900,000 8.960% |
-100,000 (-2.50%) |
Filing History |
| 2024-02-07 07:45 am Sale |
2023-12-31 | 13G | Rain Enhancement Technologies Holdco Inc RAIN |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-1,523,282 (Position Closed) |
Filing History |
| 2024-02-07 07:44 am Sale |
2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
ADAGE CAPITAL PARTNERS GP L.L.C. | 1,506,422 2.440% |
-1,964,125 (-56.59%) |
Filing History |
| 2024-02-07 07:43 am Sale |
2023-12-31 | 13G | Adams Natural Resources Fund, Inc. PEO |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-1,308,791 (Position Closed) |
Filing History |
| 2024-02-07 07:43 am Sale |
2023-12-31 | 13G | Finance Of America Companies Inc. FOA |
ADAGE CAPITAL PARTNERS GP L.L.C. | 334,288 3.800% |
-19,592 (-5.54%) |
Filing History |
| 2024-02-07 07:43 am Unchanged |
2023-12-31 | 13G | Power & Digital Infrastructure Acquisition II Corp. XPDB |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:42 am Sale |
2023-12-31 | 13G | Sitio Royalties Corp. STR |
ADAGE CAPITAL PARTNERS GP L.L.C. | 3,947,589 4.830% |
-155,246 (-3.78%) |
Filing History |
| 2024-02-07 07:42 am Sale |
2023-12-31 | 13G | INDEPENDENCE CONTRACT DRILLING ICDIQ |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-710,757 (Position Closed) |
Filing History |
| 2024-02-07 07:41 am Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 1,291,701 2.240% |
-1,663,299 (-56.29%) |
Filing History |
| 2024-02-07 07:40 am Sale |
2023-12-31 | 13G | Catcha Investment Corp CHAA |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-1,600,000 (Position Closed) |
Filing History |
| 2024-02-07 07:40 am Sale |
2023-12-31 | 13G | 9 Meters Biopharma, Inc. NMTRQ |
ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% |
-650,000 (Position Closed) |
Filing History |
| 2024-02-07 07:39 am Sale |
2023-12-31 | 13G | NPK International Inc. NPKI |
ADAGE CAPITAL PARTNERS GP L.L.C. | 1,234,953 1.450% |
-4,778,698 (-79.46%) |
Filing History |
| 2024-02-07 07:39 am Sale |
2023-12-31 | 13G | Talos Energy Inc. TALO |
ADAGE CAPITAL PARTNERS GP L.L.C. | 2,805,360 2.260% |
-3,607,138 (-56.25%) |
Filing History |
| 2024-02-07 07:38 am Sale |
2023-12-31 | 13G | Vinci Partners Investments Ltd. VINP |
ADAGE CAPITAL PARTNERS GP L.L.C. | 2,011,610 5.100% |
-1,150,271 (-36.38%) |
Filing History |
| 2024-02-07 07:37 am Sale |
2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 500,000 0.670% |
-3,918,962 (-88.69%) |
Filing History |